Mira Stock Analysis Mira Pharmaceuticals Inc. Rises 4.72 Pct To Hold 1.11 Level 20260403 1 IDT Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operational Performance TSEM Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Chinese AI Firms Zhipu and Minimax Rally on Reports of Potential Hang Seng Index Inclusion UAVS Q3 2023 Earnings Narrowed Loss per Share Amid Strategic Restructuring Indian Indices Edge Higher Amid Mixed Signals Geopolitical Risks Weigh on Sentiment ADTN Q1 2026 Earnings Earnings Beat Expectations as EPS Surges 47 Above Estimates WTTR Q1 2026 Earnings EPS Surges 106 Above Estimates as Water Solutions Sector Strengthens